Tvardi Therapeutics, Inc. — Director's Dealing 2018

Jul 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cara Therapeutics, Inc. (CARA)
CIK: 0001346830
Period of Report: 2018-07-02

Reporting Person: Menzaghi Frederique Ph.D. (Sr VP-Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-02	Common Stock	S	3000	$19.00	Disposed	104000	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2017.